Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccinationArticle Published on 2022-09-162022-11-15 Journal: Vaccine [Category] SARS, 진단, [키워드] acute respiratory syndrome age Analysis analyzed Anti-spike antibody antibody level Antibody titre BNT162b2 BNT162b2 vaccine Care conducted coronavirus disease coronavirus disease-2019 Coronavirus-2 COVID-19 decrease dose Factor female females healthcare healthcare worker Healthcare workers hospital IgG IgG antibody Japanese negative correlation participant Participants preserved Prospective Study Protein Regression SARS-CoV-2 side Side effects tested the vaccine vaccination were infected [DOI] 10.1016/j.vaccine.2022.08.035 PMC 바로가기
Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infectionArticle Published on 2022-09-162022-11-15 Journal: Vaccine [Category] SARS, 변종, 진단, [키워드] administration antibody antibody level Antibody Response BNT162b2 vaccine booster booster dose booster vaccination COVID-19 decrease Delta evaluated HCW HCWs healthcare worker humoral immune response immune immunisation Immunisation safety Immunity immunogenicity data increase in Infection much higher naïve Neutralizing antibodies of BNT162b2 omicron Omicron variant resulting SARS-CoV-2 second dose second vaccination severe symptoms Support the vaccine threshold Vaccine variant virus [DOI] 10.1016/j.vaccine.2022.08.045 PMC 바로가기
Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity중증 비만 환자의 SARS-CoV-2 백신에 대한 항체 반응Article Published on 2022-09-012022-09-11 Journal: Obesity surgery [Category] COVID19(2023년), MERS, SARS, 진단, 치료법, [키워드] age antibody antibody level antibody levels Antibody Response Antibody titer Antibody titers anticipated Antigen blood sample Blood samples BMI BNT162b2 BNT162b2 mRNA BNT162b2 vaccine BNT162b2 vaccines consecutive patient Control control group CoronaVac Course COVID-19 COVID-19 vaccination determined by disease domain dose dose of vaccination Effectiveness enrolled female IgG antibody IgG antibody titers inactivated individual Infection information male mRNA normal weight not significantly different obesity of BNT162b2 Patient presenting Quantitative recruited reduced response SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgG antibody SARS-COV-2 infection SARS-CoV-2 spike antigen SARS-CoV-2 vaccination SARS-CoV-2 vaccine serological Severe obesity significantly significantly higher significantly lower spike-protein subject vaccination Vaccine Vaccines vulnerable population was performed weight control were measured [DOI] 10.1007/s11695-022-06181-y PMC 바로가기 [Article Type] Article
Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home CohortArticle Published on 2022-09-012022-11-15 Journal: JAMA Network Open [Category] SARS, 변종, 진단, [키워드] 95% CI absorbance Ad26.COV2.S age Analysis Anti-RBD IgG antibody antibody level Antibody Response association binding domain blood sample BNT162b2 booster booster doses Breakthrough infection calculated calibrator COVID-19 COVID-19 vaccination COVID-19 vaccine cross-sectional Delta demonstrated effective home Humoral immunity IgG IgG level increased risk individual Infection Level median multivariate no difference Nursing omicron outcome participant persistence populations Potential protective role regression modeling RNA-1273 SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 surveillance SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 variant Sex significantly higher significantly lower specimen subsequent the mean vaccination Vaccine Virginia were assessed West white [DOI] 10.1001/jamanetworkopen.2022.31334 PMC 바로가기
Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study고형암 환자에서 SARS-CoV-2 백신접종에 대한 혈청학적 반응에 영향을 미치는 요인: 전향적 연구Observational Study Published on 2022-09-012022-09-12 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] addition affecting analyzed Anti-SARS-CoV-2 S antibody antibody level Antibody test baseline blood sample BNT162b2 Cancer Chemotherapy CLIA clinical feature clinical study collected CoronaVac CoronaVac. COVID-19 demographic determine diagnoses dose enzyme evaluate Factor first dose IgG antibody IgG level immunoassay in both groups inactivated men mRNA vaccine of BNT162b2 oncology Patient Patients with cancer positive preventive measure proportion Prospective Study Quantitative RBD receiving Receptor binding domain SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 PCR SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines second dose Serologic response Sex significantly significantly higher single-center study solid tumor solid tumors vaccination Vaccine Vaccines virus spike protein was determined were excluded were measured [DOI] 10.1016/j.jiac.2022.05.021 PMC 바로가기 [Article Type] Observational Study
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)광범위한 면역 손상 조건에 걸친 코로나바이러스 질병 2019(COVID-19) 백신 반응의 전향적 평가: 면역 손상 연구(COVICS)의 COVID-19 백신 접종Article Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, [키워드] acute respiratory syndrome adenovirus vector vaccine age anti-CD20 antibody antibody level Antibody Response approach autoimmune condition autoimmune conditions BNT162b2 cause comparison coronavirus coronavirus disease correlated correlation COVID-19 COVID-19 vaccine COVID-19 vaccines domain Factor greater HCW HCWs healthcare worker Hematologic malignancy Hematological malignancy HIV Human immunodeficiency virus Humoral response identify Immunocompromised immunocompromised adult immunocompromised individual Immunocompromised patient immunodeficiency Immunoglobulin Immunosuppression Logistic regression lowest Messenger RNA Moderna monoclonal monoclonal antibodies mRNA-1273 neutralization titer neutralization titers outcome participant Pfizer Primary outcome proportion Prospective pseudovirus reactive recipient recipients response SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 neutralization secondary seropositive seropositive participant significantly lower solid cancers solid organ transplant solid tumor SOT Spearman Spectrum vaccination Vaccine was used [DOI] 10.1093/cid/ciac103 PMC 바로가기 [Article Type] Article
The Effect of Gestational Age at BNT162b2 mRNA Vaccination on Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody LevelsBNT162b2 mRNA 백신 접종 시 재태 연령이 산모 및 신생아 중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2) 항체 수준에 미치는 영향Article Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, [키워드] acute respiratory syndrome age Antenatal anti-S antibody antibody level antibody transfer antibody waning benefit Blood BNT162b2 mRNA booster dose Care collected coronavirus coronavirus 2 Coronavirus disease 2019 COVID-19 early gestation Effect evaluated Evaluating highest IgG level immunization implication infancy Level lowest Maternal mRNA vaccination Neonatal parturient Pregnancy Receptor binding domain respiratory SARS-CoV-2 SARS-CoV-2 BNT162b2 SARS-CoV-2 spike protein sera serology severe disease significantly higher vaccination Vaccination strategies Vaccine vaccine dose [DOI] 10.1093/cid/ciac135 PMC 바로가기 [Article Type] Article
Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposureArticle Published on 2022-08-102022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] accompanied analyzed anti-SARS-CoV-2 IgG Anti-spike antibody level antigen-specific B cell Atypical B cell CD4 CD4 T cell Cell cellular cellular response circulating control groups correlated effector memory evaluated germinal center (GC) healthy volunteer humoral immune response Immunity induce long-lived plasma cell MBC memory memory B memory B cell memory B cell (MBC) mounted mRNA vaccination neutralizing capacity Patient patients persistent plasmablast Reactions recall reduction rheumatoid arthritis rituximab (RTX) RTX SARS-CoV-2 SARS-CoV-2 IgG antibody SARS-CoV-2 vaccination second vaccination seroconverted Seven significantly spike-specific T cell Steady state therapy treated patient Treatment vaccination vaccine-mediated immunity [DOI] 10.3389/fimmu.2022.943476 PMC 바로가기
Antibody responses to the SARS-CoV-2 vaccines in hemodialysis patients: Is inactivated vaccine effective?혈액투석 환자에서 SARS-CoV-2 백신에 대한 항체 반응: 불활성화 백신이 효과적인가?Article Published on 2022-08-012022-09-11 Journal: Therapeutic apheresis and dialysis : official peer [Category] MERS, SARS, 진단, 치료기술, [키워드] antibody antibody level antibody levels Antibody Response carried Comparative control group COVID-19 detected antibody dose Effectiveness General population generate healthy volunteers Hemodialysis humoral Humoral response humoral responses immunization inactivated Inactivated vaccine investigated Maintenance hemodialysis mRNA mRNA vaccine mRNA vaccines Patient patients Receptor binding domain reduced SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 vaccine SARS-CoV-2 vaccines Seropositivity significantly lower Spike protein symptomatic infection the SARS-CoV-2 Vaccine vaccine group Vaccines were measured while [DOI] 10.1111/1744-9987.13752 PMC 바로가기 [Article Type] Article
Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titresCOVID-19에 대한 회복기 혈장: 높은 중화 항체 역가와 관련된 기증자 인구 통계학적 요인Article Published on 2022-08-012022-09-11 Journal: Transfusion medicine (Oxford, England) [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] antibody antibody level antibody levels Asian association Better clinical factor convalescent plasma COVID-19 COVID-19 pandemic demographic factor Donor donors ELISA England evaluated help high neutralising antibody hospitalised IgG antibodies IgG antibody less levels of antibodies male MOST multivariable logistic regression multivariable logistic regression model Older plasma predicted predictor Probability SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody SARS-COV-2 infection SARS-CoV-2 variants second wave supply tested therapeutic titre treatment for COVID-19 was used white with COVID-19 [DOI] 10.1111/tme.12868 PMC 바로가기 [Article Type] Article